Inactive Instrument

Highlights Easton Pharmaceuticals Inc. Other OTC

Equities

EAPH

US2777741057

Highlights

Unlock all the news: Be the first to know and act before the market!

Parallel Industries Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2021	22/12/21	CI
Easton Pharmaceuticals Inc. cancelled the acquisition of Boutique Hotel and Real Estate Asset in the Heart of Toronto, Ontario, Canada.	26/09/19	CI
Easton Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	13/06/19	CI
Easton Pharmaceuticals Inc. acquired Supreme Sweets Inc. from Barbara and Mario Parravano.	25/04/19	CI
Easton Pharmaceuticals Inc. Signs LOI with Licensed Producer of Cannabis to Expand its Operations and Participate in its Cannabis Edibles Division	27/03/19	CI
Easton Pharmaceuticals Inc. Commences Cannabis Edibles Division	10/03/19	CI
Easton Pharmaceuticals Inc. Announces Updates on its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives	05/02/19	CI
Easton Pharmaceuticals Inc. Provides Operational Update on CAD 2,600,000 Framing Contract	11/01/19	CI
Easton Pharmaceuticals Announces Signing and Commencement of CAD 2,600,000 Framing Contract to Construct 150 Homes	02/01/19	CI
Gunpowder Capital Corp. cancelled the acquisition of iBliss Inc. from Easton Pharmaceuticals Inc..	28/11/18	CI
Easton Pharmaceuticals Reaches Agreement to Take Over Hotel and $17,000,000 Real Estate Asset in Heart of Toronto, Canada	27/09/18	GL
Easton Pharmaceuticals Inc. signed a letter of intent to acquire Boutique Hotel and Real Estate Asset in the Heart of Toronto, Ontario, Canada.	26/09/18	CI
Easton Mulls Acquisitions Of Operating Casino and Hotel Resort in Greece	22/08/18	CI
Easton Pharmaceuticals Acquires Interest in Development Project with in Excess of CAD 30 Million in Profit	20/08/18	CI
Gunpowder Capital Corp. signed a letter of intent to acquire iBliss Inc. from Easton Pharmaceuticals Inc. for CAD 0.65 million.	03/06/18	CI
Easton Pharmaceuticals Announces Sub-Distribution Agreement with BAYER and BAYER Consumer Care of Switzerland	16/04/18	CI
Easton Pharmaceuticals, Inc. and BMV Medica S.A. de C.V. Announce Signing of a Closed Sub-Distribution Agreement	25/01/18	CI
Easton Pharmaceuticals, Inc. and BMV Medica S.A. de C.V. Signs Closed Sub-Distribution Agreement with the Legal Entity of BAYER's Consumer Health Division	25/01/18	CI
Easton Pharmaceuticals & Partner BMV Medica Announce Delivery and Launch of AmnioSense (AL-Sense) in Mexico	06/12/17	CI
Easton Pharmaceuticals Inc. Enters into Sub-Distribution Agreement with Gedeon Richter Plc and Gedeon Richter S.A.P.I de C.V. for AmnioSense	12/08/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Easton Pharmaceuticals Inc. Other OTC

Equities

EAPH

US2777741057

Highlights

Filters